C
Claudine Mazurier
Researcher at London Fire Brigade
Publications - 110
Citations - 5908
Claudine Mazurier is an academic researcher from London Fire Brigade. The author has contributed to research in topics: Von Willebrand factor & Von Willebrand disease. The author has an hindex of 38, co-authored 110 publications receiving 5637 citations. Previous affiliations of Claudine Mazurier include Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J E Sadler,U. Budde,Jeroen Eikenboom,Emmanuel J. Favaloro,Frank Hill,Lars Holmberg,Jørgen Ingerslev,Christine A. Lee,David Lillicrap,P. M. Mannucci,Claudine Mazurier,Dominique Meyer,William L. Nichols,M. Nishino,Ian R. Peake,F. Rodeghiero,Reinhard Schneppenheim,Zaverio M. Ruggeri,A. Srivastava,Robert R. Montgomery,Augusto B. Federici +20 more
TL;DR: Six categories of von Willebrand disease correlate with important clinical features and therapeutic requirements, and certain VWD types, especially type 1 and type 2A, encompass several pathophysiologic mechanisms that sometimes can be distinguished by appropriate laboratory studies.
Journal ArticleDOI
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
Alberto Tosetto,Francesco Rodeghiero,Giancarlo Castaman,Anne Goodeve,Augusto B. Federici,Javier Batlle,Dominique Meyer,Edith Fressinaud,Claudine Mazurier,Jenny Goudemand,Jeroen Eikenboom,Reinhard Schneppenheim,U. Budde,Jørgen Ingerslev,Zdena Vorlova,David Habart,Lars Holmberg,Stefan Lethagen,John Pasi,Frank Hill,Ian R. Peake +20 more
TL;DR: Higher BS was related with increasing likelihood of VWD, and a mucocutaneous BS was strongly associated with bleeding after surgery or tooth extraction, which is potentially useful for a more accurate diagnosis of type 1 VWD.
Journal ArticleDOI
Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD)
Anne Goodeve,Jeroen Eikenboom,Giancarlo Castaman,Francesco Rodeghiero,Augusto B. Federici,Javier Batlle,Dominique Meyer,Claudine Mazurier,Jenny Goudemand,Reinhard Schneppenheim,Ulrich Budde,Jørgen Ingerslev,David Habart,Zdena Vorlova,Lars Holmberg,Stefan Lethagen,John Pasi,Frank Hill,Mohammad Hashemi Soteh,Luciano Baronciani,Christer Halldén,Andrea Guilliatt,Will Lester,Ian R. Peake +23 more
TL;DR: This study recruited families based on previous type 1 VWD diagnosis and stratified patients into those with or without phenotypes suggestive of qualitative VWF defects (abnormal multimers) and with or with mutations.
Journal ArticleDOI
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study
Stylianos E. Antonarakis,J. P. Rossiter,M. Young,J. Horst,P. De Moerloose,S. S. Sommer,Rhett P. Ketterling,H. H. Kazazian,Claude Negrier,Christine Vinciguerra,Jane Gitschier,Michel Goossens,E. Girodon,N. Ghanem,F. Plassa,Jean-Maurice Lavergne,M. Vidaud,J. M. Costa,Y. Laurian,S. W. Lin,S. R. Lin,M. C. Shen,David Lillicrap,Sherryl A. M. Taylor,S. Windsor,Sophie Valleix,K. Nafa,Y. Sultan,Marc Delpech,Cindy L. Vnencak-Jones,John A. Phillips,Rolf Ljung,E. Koumbarelis,A. Gialeraki,T. Mandalaki,P. V. Jenkins,Peter William Collins,K. J. Pasi,Anne Goodeve,Ian R. Peake,F. E. Preston,Marianne Schwartz,Elma Scheibel,Jørgen Ingerslev,David Neil Cooper,David Stuart Millar,V. V. Kakkar,F. Giannelli,J.A. Naylor,E. F. Tizzano,M. Baiget,M. Domenech,Carmen Altisent,J. Tusell,M. Beneyto,J. I. Lorenzo,Christine Gaucher,Claudine Mazurier,Kathelijne Peerlinck,Gert Matthijs,Jj. Cassiman,Jozef Vermylen,P. G. Mori,M. Acquila,D. Caprino,Hiroshi Inaba +65 more
TL;DR: The presence of factor VII inversions is not a major predisposing factor for the development of factor VIII inhibitors; however, slightly more patients with severe hemophilia A and factor VIII inversions develop inhibitors than patients without inversions.
Journal ArticleDOI
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
Augusto B. Federici,Claudine Mazurier,Erik Berntorp,Christine A. Lee,Inge Scharrer,Jenny Goudemand,S. Lethagen,Ioana Nitu,Gerard Ludwig,Lysiane Hilbert,Pier Mannuccio Mannucci +10 more
TL;DR: The rate of biologic response to DDAVP is relatively low not only in type 2 but also in type 1 VWD when uniform and stringent criteria for patient selection and responsiveness are applied.